Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Scharf

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|February 24, 1994
Lorenzo's oil and lymphocytopeniaC J Unkrig, R Schröder, R E Scharf
Hamostaseologie|January 31, 2006
[Pregnancy-associated venous thromboembolic disease: prediction, prevention, and therapy]R B Zotz, A Gerhardt, R E Scharf
Thrombosis and Haemostasis|July 1, 1996
Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated systemR B Zotz, B Maruhn-Debowski, R E Scharf
Hamostaseologie|January 8, 2015
Management of acquired haemophilia AA Tiede, R E Scharf, C Dobbelstein, et al.
Hamostaseologie|August 4, 2010
Clinical features and outcome of acquired haemophilia A. Interim analysis of the Düsseldorf studyR Gheisari, B Bomke, T Hoffmann, et al.
European Journal of Haematology|October 1, 1990
A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disordersA Wehmeier, S Fricke, R E Scharf, et al.
Thrombosis and Haemostasis|May 24, 2000
Phenprocoumon-induced hepatitis in a patient with a combined hereditary hemostatic disorderI Bux-Gewehr, R B Zotz, R E Scharf
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 1997
[Resistance to activated protein C by mutation of the factor V gene. Most frequent blood coagulation defect in venous thromboses]D Peus, R E Scharf, I Witt, et al.
Klinische Wochenschrift|February 4, 1985
[Thrombotic thrombocytopenic purpura]C Aul, R E Scharf, T Königshausen, et al.
Haemostasis|January 1, 1989
Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the diseaseA Wehmeier, R E Scharf, S Fricke, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|February 24, 1994
Lorenzo's oil and lymphocytopeniaC J Unkrig, R Schröder, R E Scharf
Hamostaseologie|January 31, 2006
[Pregnancy-associated venous thromboembolic disease: prediction, prevention, and therapy]R B Zotz, A Gerhardt, R E Scharf
Thrombosis and Haemostasis|July 1, 1996
Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated systemR B Zotz, B Maruhn-Debowski, R E Scharf
Hamostaseologie|January 8, 2015
Management of acquired haemophilia AA Tiede, R E Scharf, C Dobbelstein, et al.
Hamostaseologie|August 4, 2010
Clinical features and outcome of acquired haemophilia A. Interim analysis of the Düsseldorf studyR Gheisari, B Bomke, T Hoffmann, et al.
European Journal of Haematology|October 1, 1990
A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disordersA Wehmeier, S Fricke, R E Scharf, et al.
Thrombosis and Haemostasis|May 24, 2000
Phenprocoumon-induced hepatitis in a patient with a combined hereditary hemostatic disorderI Bux-Gewehr, R B Zotz, R E Scharf
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 1, 1997
[Resistance to activated protein C by mutation of the factor V gene. Most frequent blood coagulation defect in venous thromboses]D Peus, R E Scharf, I Witt, et al.
Klinische Wochenschrift|February 4, 1985
[Thrombotic thrombocytopenic purpura]C Aul, R E Scharf, T Königshausen, et al.
Haemostasis|January 1, 1989
Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the diseaseA Wehmeier, R E Scharf, S Fricke, et al.
Pageof 9